Vaccine(s) were received on 10/04/2016
Vaccine(s) were received in the state: KY
Patient sex : F
Reaction was life threatening?: N
Patient eventually recovered from reaction ?: U
Patient eventually died?: N

The following Data for this patients ALLERGIES is available: [ ]

Description of adverse reaction: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient received the ZOSTAVAX (lot number, dosage and route of administration not provided) on 04-OCT-2016 from a pharmacy, for its intended purpose: the prevention of shingles. The ZOSTAVAX did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. In approximately 2016 [reported as shortly after receiving ZOSTAVAX], the patient developed an intermittent, sharp, throbbing pain and blisters on her back. The patient was diagnosed with shingles lesions and postherpetic neuralgia. The outcome of the events is unknown. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient suffered painful injuries and damages, and required extensive medical care and treatment. The patient has suffered and will conti

Vaccine(s) associated with report# 754704

Type	Name	Manufacturer	Vaccine LOT #	Dose Series	ROUTE	Site
VARZOS	ZOSTER (ZOSTAVAX)	MERCK & CO. INC.		0	UN

Symptoms(s) associated with report# 754704

Blister
Herpes zoster
Pain
Post herpetic neuralgia